Metraipolis › archive › dc_0c092a9db2ae

Combined use of insulin eye drops and cross-linked hyaluronic acid canalicular gel for the management of severe neurotrophic keratopathy — Europe PMC PMID:42569539

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42569539
DOI
10.1016/j.ajoc.2026.102637
License (as archived)
solo-consultazione
Archived
2026-10-08T01:05:58.272Z
SHA-256 of the archived text
ea58aaadb31b684f0cda65c75b79c5080a0d7933c3d33731e3bb41f427e2f6cc
Stable URL of this page
https://metraipolis.com/documento/dc_0c092a9db2ae

How to cite

Combined use of insulin eye drops and cross-linked hyaluronic acid canalicular gel for the management of severe neurotrophic keratopathy — Europe PMC PMID:42569539 — Europe PMC (en), https://europepmc.org/article/MED/42569539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0c092a9db2ae (Metraipolis archive dc_0c092a9db2ae, sha256 ea58aaadb31b684f0cda65c75b79c5080a0d7933c3d33731e3bb41f427e2f6cc)
BibTeX
@misc{dc0c092a9db2ae,
  title = {Combined use of insulin eye drops and cross-linked hyaluronic acid canalicular gel for the management of severe neurotrophic keratopathy — Europe PMC PMID:42569539},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42569539},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0c092a9db2ae; sha256 ea58aaadb31b684f0cda65c75b79c5080a0d7933c3d33731e3bb41f427e2f6cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42569539. Agents can read the archived copy with the MCP tool read_document.